Seller comparison · US self-pay prices

MEDVi vs Willow: MEDVi Is Cheaper, GLP-1 Prices Compared

Last updated

Each seller's lowest price now

  • Lowest price, compounded and not FDA-approved

    MEDVi

    $199/mo

  • Lowest price, compounded and not FDA-approved

    Willow

    from $299/mo

The same medicine for less than MEDVi and Willow, at sellers we link to

  • Compounded semaglutide, not FDA-approved

    Eden

    $99/mo · about $107 less per 30 days than MEDVi

  • Compounded tirzepatide, not FDA-approved

    Eden

    $129/mo · about $182 less per 30 days than MEDVi

They pay us if you buy, which never changes a price we show.

MEDVi and Willow both sell compounded semaglutide injection and compounded tirzepatide injection. Compounded semaglutide injection: about $100 a month less at MEDVi (about $1,200 over a year): $199/mo, against from $299/mo at Willow. Compounded tirzepatide injection: about $107 less per 30 days at MEDVi: ≈ $320 per 30 days, against from $399/mo (≈ $428 per 30 days, its month read as four weekly doses) at Willow. Both list only compounded GLP-1s here. Compounded GLP-1s are not FDA-approved. Prices checked Nov 11, 2026 and Nov 13, 2026.

Every cash quote was checked on or after . Each quote shows its own check date. A quoted price is not a recommendation of a seller, a product or a dose. How we source prices

Same product

What MEDVi and Willow charge for the same medication

Entry prices first, then the published top-dose price where either seller states one. Each price names the seller's own page it was read from.

Compounded semaglutide injection

Entry price: about $100 a month less at MEDVi (about $1,200 over a year): $199/mo, against from $299/mo at Willow.

MEDVi

Advertised entry price

$199/mo (glp1.medvi.org)

Billed per month; days of supply not on record, so ordered as four weekly doses.

Checked on glp1.medvi.org

Compounded semaglutide via MEDVi

MEDVi · seller's own price

refill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract

Price conditions

refill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract

Weekly injection. Another MEDVi landing page shows semaglutide at $116 a month in one place and $166 a month in its FAQ. MEDVi also sells a daily GLP-1 tablet from $249 without naming the drug. Compounded; not FDA-approved.

Willow

Advertised entry price

from $299/mo (startwillow.com/compound-semaglutide)

Billed per month; days of supply not on record, so ordered as four weekly doses.

Checked on startwillow.com

Compounded semaglutide via Willow

Willow · seller's own price

monthly subscription that renews automatically, cancel anytime; physician, medication, care team and shipping included; medication costs vary by dosage (Willow's FAQ)

Price conditions

monthly subscription that renews automatically, cancel anytime; physician, medication, care team and shipping included; medication costs vary by dosage (Willow's FAQ)

Weekly injection, or a daily under-the-tongue tablet at the same starting price. Willow publishes no price per dose. Availability varies by state. Compounded; not FDA-approved.

Compounded tirzepatide injection

Entry price: about $107 less per 30 days at MEDVi: ≈ $320 per 30 days, against from $399/mo (≈ $428 per 30 days, its month read as four weekly doses) at Willow. Top dose: only MEDVi publishes a top-dose price here: $299/mo at 15 mg.

MEDVi

Advertised entry price

$299/mo (glp1.medvi.org/results/cv-tirz)

28-day supply (glp1.medvi.org)

≈ $320.36 per 30 days at this quoted rate

Checked on glp1.medvi.org

Compounded tirzepatide via MEDVi

MEDVi · seller's own price

monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)

Price conditions

monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)

Weekly injection. Another MEDVi landing page shows tirzepatide at $166 a month, and $199 a month in its FAQ. Multi-month packages are not refunded for unused months. Compounded; not FDA-approved.

28-day supply

Published maintenance dose

$299/mo (glp1.medvi.org/results/cv-tirz)

28-day supply (glp1.medvi.org)

≈ $320.36 per 30 days at this quoted rate

Checked on glp1.medvi.org

At 15 mg

Compounded tirzepatide via MEDVi

MEDVi · seller's own price

monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)

Price conditions

monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)

Weekly injection. Another MEDVi landing page shows tirzepatide at $166 a month, and $199 a month in its FAQ. Multi-month packages are not refunded for unused months. Compounded; not FDA-approved.

The seller states one price at every dose, so this is also its price at 15 mg.

28-day supply

Willow

Advertised entry price

from $399/mo (startwillow.com/compound-tirzepatide)

Billed per month; days of supply not on record, so ordered as four weekly doses.

Checked on startwillow.com

Compounded tirzepatide via Willow

Willow · seller's own price

monthly subscription that renews automatically, cancel anytime; physician, medication, care team and shipping included; medication costs vary by dosage (Willow's FAQ)

Price conditions

monthly subscription that renews automatically, cancel anytime; physician, medication, care team and shipping included; medication costs vary by dosage (Willow's FAQ)

Weekly injection, or a daily dissolving tablet at the same starting price. Willow publishes no price per dose. Availability varies by state. Compounded; not FDA-approved.

Published maintenance dose

No dose-specific quote tracked.

Same medication, lower price

Cheaper than MEDVi and Willow

Other sellers' current prices for the same product, below the lower of these two, compared per 30 days where both state their supply. Compounded medication is compared only with compounded, and an FDA-approved product only with itself.

Compounded, not FDA-approved

Compounded semaglutide

Lower than both. MEDVi: $199/mo, checked Nov 11, 2026 on glp1.medvi.org.

  1. Collective: $59/mo + $199/yr membership. Checked Nov 15, 2026 on collective.org.View offer
  2. Sunlight: $78/mo, about $84 per 30 days. Checked Nov 11, 2026 on sunlight.com.View offer
  3. Avono Health: $79/mo. Checked Nov 13, 2026 on avonohealth.com.View offer
  4. Embody: $79/mo. Checked Nov 14, 2026 on joinem.co.View offer

Compounded, not FDA-approved

Compounded tirzepatide

Lower than both. MEDVi: $299/mo, checked Nov 13, 2026 on glp1.medvi.org.

  1. Collective: $69/mo + $199/yr membership. Checked Nov 15, 2026 on collective.org.View offer
  2. FlatRx: $118/mo. Checked Nov 17, 2026 on flatrx.io.View offer
  3. Arbor: $119/mo. Checked Nov 13, 2026 on startarbor.com.View offer
  4. Mint Med: $119/mo. Checked Nov 11, 2026 on mintmed.com.View offer

Compounded GLP-1s are not FDA-approved. Compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness or quality before they are marketed. FDA: concerns with unapproved GLP-1 drugs used for weight loss (fda.gov)

Questions

MEDVi vs Willow: common questions

Is MEDVi or Willow cheaper for GLP-1 medication?

Compounded semaglutide injection: about $100 a month less at MEDVi (about $1,200 over a year): $199/mo, against from $299/mo at Willow. Compounded tirzepatide injection: about $107 less per 30 days at MEDVi: ≈ $320 per 30 days, against from $399/mo (≈ $428 per 30 days, its month read as four weekly doses) at Willow. At the top published dose, only MEDVi publishes a top-dose price here: $299/mo at 15 mg. Prices are the sellers' own advertised self-pay prices, with the conditions listed beside each.

Do MEDVi and Willow sell FDA-approved GLP-1s or compounded versions?

Both list only compounded GLP-1s here. Compounded GLP-1s are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality.

What do MEDVi and Willow prices include?

MEDVi, compounded semaglutide injection: $199/mo, refill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract. Willow, compounded semaglutide injection: from $299/mo, monthly subscription that renews automatically, cancel anytime; physician, medication, care team and shipping included; medication costs vary by dosage (Willow's FAQ). MEDVi, compounded tirzepatide injection: $299/mo, monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months). Willow, compounded tirzepatide injection: from $399/mo, monthly subscription that renews automatically, cancel anytime; physician, medication, care team and shipping included; medication costs vary by dosage (Willow's FAQ).

When were MEDVi and Willow prices last checked?

Prices checked Nov 11, 2026 and Nov 13, 2026. Each quote names the seller's own page it was read from. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.

Every sourced offer

All MEDVi and Willow offers

Both sellers' quotes in one table, lowest 30-day cost first where the seller states its supply.

4 current prices

Lowest starting 30-day cost ·

  • View
    $199/mo (glp1.medvi.org)

    Checked on glp1.medvi.org

    Top dose: No separate price on record

    Terms & source

    Advertised price: refill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract

    Billed per month; days of supply not on record, so ordered as four weekly doses.

    Weekly injection. Another MEDVi landing page shows semaglutide at $116 a month in one place and $166 a month in its FAQ. MEDVi also sells a daily GLP-1 tablet from $249 without naming the drug. Compounded; not FDA-approved.

    Partner: This seller may pay us a referral fee if you buy through our link, at no extra cost to you. That moves it up in our default order, never in a lowest-cost sort, and is not a medical recommendation.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (glp1.medvi.org)
  • View
    from $299/mo (startwillow.com/compound-semaglutide)

    Checked on startwillow.com

    Top dose: No separate price on record

    Terms & source

    Advertised price: monthly subscription that renews automatically, cancel anytime; physician, medication, care team and shipping included; medication costs vary by dosage (Willow's FAQ)

    Billed per month; days of supply not on record, so ordered as four weekly doses.

    Weekly injection, or a daily under-the-tongue tablet at the same starting price. Willow publishes no price per dose. Availability varies by state. Compounded; not FDA-approved.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (startwillow.com)
  • View
    $299/mo (glp1.medvi.org/results/cv-tirz)

    ≈ $320.36 per 30 days

    Checked on glp1.medvi.org

    Top dose: same price at 15 mg

    Terms & source

    Advertised price: monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)

    28-day supply (glp1.medvi.org)

    ≈ $320.36 per 30 days at this quoted rate

    Other plan lengths

    • $193/mo on 3 months
    • $183/mo on 6 months
    • $166/mo on 12 months

    Top-dose terms: The seller states one price at every dose, so this is also its price at 15 mg.

    Weekly injection. Another MEDVi landing page shows tirzepatide at $166 a month, and $199 a month in its FAQ. Multi-month packages are not refunded for unused months. Compounded; not FDA-approved.

    Partner: This seller may pay us a referral fee if you buy through our link, at no extra cost to you. That moves it up in our default order, never in a lowest-cost sort, and is not a medical recommendation.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (glp1.medvi.org)
  • View
    from $399/mo (startwillow.com/compound-tirzepatide)

    Checked on startwillow.com

    Top dose: No separate price on record

    Terms & source

    Advertised price: monthly subscription that renews automatically, cancel anytime; physician, medication, care team and shipping included; medication costs vary by dosage (Willow's FAQ)

    Billed per month; days of supply not on record, so ordered as four weekly doses.

    Weekly injection, or a daily dissolving tablet at the same starting price. Willow publishes no price per dose. Availability varies by state. Compounded; not FDA-approved.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (startwillow.com)
  • Check price

    No current cited price verified

    Top dose: No separate price on record

    Terms & source

    Advertised price: its tirzepatide tablets order page shows "$399" and, beside it, "one time for $299" and "subscribe for $299", and its own tablets page says "$399 /mo", so the pages disagree on the price and no figure is compared

    A daily oral dissolving tablet: "Tirzepatide is a compounded medication and is not FDA-approved." No approved tirzepatide tablet exists, so it can only be compounded. Compounded; not FDA-approved.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (startwillow.com)

Read prices in context. Compare the same product, dose and payment terms; missing prices are not estimated. Compounded medicines are not FDA-approved.

How this list is ordered. Some sellers may pay us a referral fee, as their terms say. In this sort they are not moved up, and it never changes what you pay.

How prices are compared, what FDA says about compounding and how we earn

A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes, converted to 30 days: by the supply a price buys where the seller states it in days, otherwise a monthly price with its plan length on record read as four weekly doses, a yearly membership in the price spread over twelve months. Introductory prices, ranges, prices with no plan length on record and separately billed fees are unranked references. Dose changes and added fees affect what you pay.

A listed maintenance dose is not a dosing recommendation.

FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved (fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize). Its conditions for a pharmacy compounding them now include "The drug product is compounded for an individual patient based on receipt of a prescription" and "The compounder does not compound, regularly or in inordinate amounts, any that are essentially copies of a commercially available drug product." (fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize) In May 2026 FDA proposed leaving semaglutide, tirzepatide and liraglutide off the 503B Bulks List (federalregister.gov/documents/2026/05/01/2026-08552/list-of-bulk-drug-substances-for-which-there-is-a-clinical-need-under-section-503b-of-the-federal), the ingredients outsourcing facilities may compound from; comments closed Jul 30, 2026 (govinfo.gov/content/pkg/FR-2026-06-26/html/2026-12937.htm), and we found no final notice when we last read the Federal Register (Nov 6, 2026). FDA's newest warning letter to a pharmacy over compounded semaglutide or tirzepatide went to Empower Clinic Services, LLC dba Empower Pharmacy (fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/empower-clinic-services-llc-dba-empower-pharmacy-738238-09182026) on Sep 18, 2026 (every GLP-1 warning letter). FDA's newest recall report of a compounded semaglutide or tirzepatide product is Houston Rx LLC's tirzepatide (api.fda.gov/drug/enforcement.json), reported Oct 21, 2026: "Lack of assurance of sterility." (every tirzepatide recall). Liraglutide is different: FDA's shortage database (accessdata.fda.gov/scripts/drugshortages) still lists it in shortage (updated at source Oct 14, 2026; every GLP-1 shortage). FDA: "Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed." (fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers) A low price is not a low-risk signal; confirm current terms with the provider.

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

Public record

MEDVi vs Willow: reviews, BBB and FDA

What Trustpilot, the BBB and the FDA say about each. These records do not measure medical quality or results.

MEDVi

Trustpilot 4.3 from 15,227 reviews. The BBB rates MEDVi F, with 789 complaints filed in the last 3 years. It is not BBB accredited. The FDA sent MEDVi a warning letter (Feb 20, 2026) about claims on its website. The words that letter quotes ("Same active ingredient as Wegovy® and Ozempic®") were on none of the 3 pages of home.medvi.org and glp1.medvi.org we read on Nov 16, 2026.

Is MEDVi legit?

Willow

Trustpilot 4.1 from 386 reviews. We found no BBB profile that names Willow's site. We found no FDA warning letter naming Willow as of Nov 6, 2026.

Is Willow legit?

Seller pages re-read automatically : 5 of 5 opened and checked for price changes. How prices stay current

Updated automatically

MEDVi and Willow price changes

  • Seller recordMEDVi: updated record on its public ratings and records
  • Seller recordWillow: updated record on whether a video visit is required (read on startwillow.com)
  • PriceSeller listed without a price we compare: Willow, Compounded tirzepatide dissolving tablets via Willow (Product price not verified) (read on startwillow.com)
  • Seller recordWillow: record on whether a video visit is required removed
  • PriceMEDVi: Compounded tirzepatide via MEDVi now ranked per 30 days at about $320: $299/mo buys 28 days (read on glp1.medvi.org)
  • Seller recordWillow: updated record on who makes its medicine (read on startwillow.com)

Written from each source's own record as it changes. Every change on GLPcompare

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.